STK3 and cancer: hsa-miR-5585-3p_L-3R-1_1ss5AG and hsa-mir-7851-p5_1ss12AC targeting AKT serine/threonine kinase 3 (AKT3) played swinging roles in the tumorigenesis, development, and progression of various types of cancer, including CRC [31–33].